Ciprofloxacin Quantification with Nuclear Magnetic Resonance Spectroscopy in a Deuterium-Free Environment
Abstract
The quantitative nuclear magnetic resonance (qNMR) method of quantifying the content of pharmaceuticals is an important and growing science in the current era. The deuterium-based solvents contribute to the main costs of the NMR-based analysis. In this study, we introduced the use of deuterium-free solvent (i.e., water H2O) for the quantification of ciprofloxacin (CIP) using the qNMR method. p-Nitrophenol (PNP) was used as an internal standard to solve the absolute integration of signals in NMR spectra. Quantification results were compared with literature-reported high-performance liquid chromatographic (HPLC) methods and analyzed by analysis of variance (ANOVA). The ANOVA results show that the regression model is highly significant (F = 37515.62, p < 0.001), indicating that the actual quantity of the analyte is a powerful predictor of the quantized concentration. An ANOVA study demonstrated that using simple water as a solvent in the qNMR method is as effective as the HPLC method for the quantitative analysis of CIP. The investigated method accurately compensated for the deficiencies of the current HPLC method for quantitative measurement of CIP, and the use of PNP overcame the problem of absolute integration of signals associated with NMR spectra.
Keywords
About the Authors
M. AzamPakistan
Muhammad Azam - Department of Chemistry, University of Okara.
A. A. Altaf
Pakistan
Ataf Ali Altaf - Department of Chemistry, University of Okara; Institute of Chemistry, Khwaja Fareed University of Engineering and Information Technology.
Rahim Yar Khan
M. Hamayun
Pakistan
Muhammad Hamayun - Department of Chemistry, University of Gujrat.
References
1. M. Kumar, R. Bhatia, R. K. Rawal, J. Pharm. Biomed. Anal., 157, 122–136 (2018).
2. R. Abazari, A. R. Mahjoub, J. Shariati, J. Hazard Mater., 366, 439–451 (2019).
3. G. A. Shabir, J. Chromatogr. A, 987, No. 1-2, 57–66 (2003).
4. S.-C. Chow, J.-P. Liu, Design and Analysis of Clinical Trials: Concepts and Methodologies, John Wiley & Sons, 507 (2008).
5. N. L. Calvo, R. M. Maggio, T. S. Kaufman, J. Pharm. Biomed. Anal., 147, 538–564 (2018).
6. M. R. Siddiqui, Z. A. Al Othman, N. Rahman, Arabian J. Chem., 10, S1409–S1421 (2017).
7. S. Mathkar, et al., J. Pharm. Biomed. Anal., 49, No. 3, 627–631 (2009).
8. R. K. Gilpin, C. S. Gilpin, Anal. Chem., 83, No. 12, 4489–4507 (2011).
9. V. D’Atri, et al., Anal. Chem., 91, No. 1, 210–239 (2018).
10. J. W. Allwood, R. Goodacre, Phytochem. Anal., 21, No. 1, 33–47 (2010).
11. T. Alvarez-Segura, et al., Anal. Chim. Acta, 923, 1–23 (2016).
12. P. K. Sahu, et al., J. Pharm. Biomed. Anal., 147, 590–611 (2018).
13. T. Tome, et al., Org. Proc. Res. Dev., 23, No. 9, 1784–1802 (2019).
14. H. Küpper, S. Seibert, A. Parameswaran, Anal. Chem., 79, No. 20, 7611–7627 (2007).
15. M. J. Swartz, Liq. Chromatogr. Rel. Technol., 33, No. 9-12, 1130–1150 (2010).
16. C. F. Poole, J. Chromatogr. A, 1421, 137–153 (2015).
17. J. Pezzatti, et al., Anal. Chim. Acta, 1105, 28–44 (2020).
18. S. Saadi, et al., Food Chem., 132, No. 1, 603–612 (2012).
19. D. Giron, C. Goldbronn, J. Therm. Anal. Calorim., 44, No. 1, 217–251 (1995).
20. E. Deconinck, et al., J. Pharm. Biomed. Anal., 70, 64–70 (2012).
21. A. A. Asfaw, et al., J. Sep. Sci., 42, No. 1, 214–225 (2019).
22. Y. Xie, et al., Molecules, 28, No. 2, 765 (2023).
23. R. J. Wells, et al., J. Agric. Food Chem., 50, No. 12, 3366–3374 (2002).
24. A. C. Dona, et al., Anal. Chem., 86, No. 19, 9887–9894 (2014).
25. E. J. Saude, C. M. Slupsky, B. D. Sykes, Metabolomics, 2, 113–123 (2006).
26. S. K. Bharti, R. Roy, TrAC – Trends Anal. Chem., 35, 5–26 (2012).
27. N. Mitschke, S. Vemulapalli, T. Dittmar, Environ. Chem. Lett., 21, No. 2, 689–723 (2023).
28. J. Ø. Duus, C. H. Gotfredsen, K. Bock, Chem. Rev., 100, No. 12, 4589–4614 (2000).
29. R. J. Wells, J. Cheung, Sci. Direct. Work Pap., 4, 157–331 (2001).
30. M. Malet-Martino, U. Holzgrabe, J. Pharm. Biomed. Anal., 55, No. 1, 1–15 (2011).
31. U. Dr. Holzgrabe, Prog. Nucl. Magn. Res. Spectrosc., 57, 229–240 (2010).
32. R. J. Wells, J. Cheung, J. M. Hook, Accredit. Qual. Assur., 9, No. 8, 450–456 (2004).
33. S. Lee, et al., Molecules, 28, No. 22, 7568 (2023).
34. J. S. Phillips, J. J. Leary, J. Chem. Ed., 63, No. 6, 545 (1986).
35. N. M. Kassab, et al., Rev. Bras. Ciênc. Farm., 41, 507–513 (2005).
Review
For citations:
Azam M., Altaf A.A., Hamayun M. Ciprofloxacin Quantification with Nuclear Magnetic Resonance Spectroscopy in a Deuterium-Free Environment. Zhurnal Prikladnoii Spektroskopii. 2026;93(2):288-1-288-7.
JATS XML





















